LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 4701

Search options

  1. Article ; Online: Patient reflections on intensive care medicine.

    White, C

    Anaesthesia

    2023  Volume 78, Issue 4, Page(s) 411–412

    MeSH term(s) Humans ; Critical Care ; Intensive Care Units
    Language English
    Publishing date 2023-01-11
    Publishing country England
    Document type Editorial
    ZDB-ID 80033-8
    ISSN 1365-2044 ; 0003-2409
    ISSN (online) 1365-2044
    ISSN 0003-2409
    DOI 10.1111/anae.15953
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Full closure of high seas would triple the benefits.

    White, Crow

    Nature

    2023  Volume 616, Issue 7958, Page(s) 661

    MeSH term(s) Animals ; Conservation of Natural Resources/legislation & jurisprudence ; Conservation of Natural Resources/methods ; Conservation of Natural Resources/trends ; Ecosystem ; Fisheries ; Fishes ; Oceans and Seas
    Language English
    Publishing date 2023-10-04
    Publishing country England
    Document type Letter
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/d41586-023-01394-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Tipping Point: A Personal Journey and Lessons Learned.

    White, Charles

    Professional case management

    2023  Volume 28, Issue 2, Page(s) 90–93

    Language English
    Publishing date 2023-01-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2277201-7
    ISSN 1932-8095 ; 1539-0675 ; 1932-8087 ; 1529-7764
    ISSN (online) 1932-8095 ; 1539-0675
    ISSN 1932-8087 ; 1529-7764
    DOI 10.1097/NCM.0000000000000644
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Cerebro-Spinal Meningitis.

    White, C A

    The Chicago medical journal

    2023  Volume 22, Issue 12, Page(s) 529–532

    Language English
    Publishing date 2023-07-06
    Publishing country United States
    Document type Journal Article
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Hereditary Erythema.

    White, C A

    The Chicago medical journal

    2023  Volume 22, Issue 11, Page(s) 522

    Language English
    Publishing date 2023-07-06
    Publishing country United States
    Document type Editorial
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Fœtal Hydrocephalus.

    White, C A

    The Chicago medical journal

    2023  Volume 22, Issue 2, Page(s) 55–57

    Language English
    Publishing date 2023-07-06
    Publishing country United States
    Document type Journal Article
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has Arrived.

    White, C Michael

    The Annals of pharmacotherapy

    2023  Volume 58, Issue 1, Page(s) 86–88

    Abstract: In this month' ... ...

    Abstract In this month's
    MeSH term(s) Humans ; Shock, Septic/drug therapy ; Vasopressins/therapeutic use ; Renal Replacement Therapy ; Continuous Renal Replacement Therapy ; Arrhythmias, Cardiac ; Vasoconstrictor Agents/therapeutic use ; Norepinephrine/therapeutic use
    Chemical Substances Vasopressins (11000-17-2) ; Vasoconstrictor Agents ; Norepinephrine (X4W3ENH1CV)
    Language English
    Publishing date 2023-04-13
    Publishing country United States
    Document type Observational Study ; Editorial
    ZDB-ID 1101370-9
    ISSN 1542-6270 ; 1060-0280
    ISSN (online) 1542-6270
    ISSN 1060-0280
    DOI 10.1177/10600280221096881
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021.

    White, C Michael

    Journal of clinical pharmacology

    2022  Volume 62, Issue 8, Page(s) 928–934

    Abstract: The US Food and Drug Administration created the Tainted Dietary Supplement Database in 2007 to identify dietary supplements adulterated with active pharmaceutical ingredients (APIs). This article compares the determination of API adulteration in dietary ... ...

    Abstract The US Food and Drug Administration created the Tainted Dietary Supplement Database in 2007 to identify dietary supplements adulterated with active pharmaceutical ingredients (APIs). This article compares the determination of API adulteration in dietary supplements from the 10-year time period of 2007 through 2016 to the most recent 5-year period of 2017 through 2021. From 2007 through 2021, 1068 unique products were found to be adulterated with APIs. Sexual enhancement and weight loss dietary supplements are the most common products adulterated with APIs. Phosphodiesterase-5 inhibitors are commonly included in sexual enhancement dietary supplements and a single product can include up to 5 APIs. Sibutramine, a drug removed from the market due to cardiovascular adverse events, is the most included adulterant API in weight loss products, although sibutramine analogues, phenolphthalein (which was removed from the US market because of cancer risk), and fluoxetine were also included. While muscle-building dietary supplements were commonly adulterated before 2016, since 2017 no additional adulterated products have been identified. The lack of disclosure of APIs in dietary supplements, circumventing the normal procedure with clinician oversight of prescription drug use, and the use of APIs that are banned by the Food and Drug Administration or used in combinations that were never studied are important health risks for consumers.
    MeSH term(s) Dietary Supplements/adverse effects ; Drug Contamination ; Humans ; Pharmaceutical Preparations ; United States ; United States Food and Drug Administration ; Weight Loss
    Chemical Substances Pharmaceutical Preparations
    Language English
    Publishing date 2022-03-31
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 188980-1
    ISSN 1552-4604 ; 0091-2700 ; 0021-9754
    ISSN (online) 1552-4604
    ISSN 0091-2700 ; 0021-9754
    DOI 10.1002/jcph.2046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Criminal Action Against Drug Counterfeiters: Assessment of the FDA Office of Criminal Investigation Database 2016 Through 2021.

    White, C Michael

    The Annals of pharmacotherapy

    2022  Volume 56, Issue 12, Page(s) 1333–1338

    Abstract: Objective: The objective of this study was to describe law enforcement oversight of counterfeit drugs by the Food and Drug Administration (FDA) in the United States from 2016 through 2021.: Methods: The FDA Office of Criminal Investigation database ... ...

    Abstract Objective: The objective of this study was to describe law enforcement oversight of counterfeit drugs by the Food and Drug Administration (FDA) in the United States from 2016 through 2021.
    Methods: The FDA Office of Criminal Investigation database with hyperlinked press releases of enforcement actions was used to identify legal action against drug counterfeiters. Incidences of counterfeit drugs sold via Internet, how often they were obtained without a prescription, the most prevalent counterfeit drugs, the countries where counterfeit operations occurred, and the scale of counterfeit operations were assessed.
    Results: There were 130 unique enforcement actions against counterfeiting organizations and individuals. Overall, 64.6% of enforcement actions involved counterfeit products sold over the Internet, in 84.6% of actions counterfeit medications could be obtained without a prescription, and in 33.1% of actions the products were sold as dietary supplements. Sexual dysfunction, opioid, stimulant, anabolic muscle building, benzodiazepine, and dermatologic drugs were most counterfeited. China was the most prevalent country to produce counterfeit drugs followed by India, Turkey, Pakistan, and Russia. Counterfeiting operations were large with tens of millions of pills and hundreds of millions of dollars in sales. Health outcomes for counterfeit drugs were rarely discussed in the press releases and not all press releases had data for each parameter of interest.
    Conclusion and relevance: This is the first report assessing enforcement actions against drug counterfeiters from the FDA Office of Criminal Investigation. The FDA is actively involved in identifying and prosecuting counterfeit drug rings, but the number of enforcement actions is smaller than the size of the problem.
    MeSH term(s) Analgesics, Opioid ; Benzodiazepines ; Counterfeit Drugs/adverse effects ; Criminals ; Humans ; Law Enforcement ; Pharmaceutical Preparations ; United States ; United States Food and Drug Administration
    Chemical Substances Analgesics, Opioid ; Counterfeit Drugs ; Pharmaceutical Preparations ; Benzodiazepines (12794-10-4)
    Language English
    Publishing date 2022-05-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1101370-9
    ISSN 1542-6270 ; 1060-0280
    ISSN (online) 1542-6270
    ISSN 1060-0280
    DOI 10.1177/10600280221092482
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Pharmacists Have the Stats but No Provider Status: Now May Be Our Moment.

    White, C Michael

    The Annals of pharmacotherapy

    2022  Volume 56, Issue 10, Page(s) 1181–1183

    MeSH term(s) Humans ; Pharmaceutical Services ; Pharmacists
    Language English
    Publishing date 2022-02-02
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1101370-9
    ISSN 1542-6270 ; 1060-0280
    ISSN (online) 1542-6270
    ISSN 1060-0280
    DOI 10.1177/10600280211036160
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top